These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6419407)

  • 1. Long-acting contraceptive agents: levonorgestrel esters of unsaturated acids.
    Wan AS; Ngiam TL; Leung SL; Go ML; Francisco CG; Freire R; Hernandez R; Salazar JA; Suarez E; García GA
    Steroids; 1983 Mar; 41(3):339-48. PubMed ID: 6419407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting contraceptive agents: aliphatic and alicyclic carboxylic esters of levonorgestrel.
    Shafiee A; Vossoghi M; Savabi F; Watson TG; Schubert K; Ponsold K; Werner W; Wagner H; Vlahov R; Tarpanov V
    Steroids; 1983 Mar; 41(3):349-59. PubMed ID: 6419408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting contraceptive agents: analysis and purification of steroid esters.
    Matlin SA; Chan L; Hadjigeogiou P; Prazeres MA; Mehani S; Roshdi S
    Steroids; 1983 Mar; 41(3):361-7. PubMed ID: 6419409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting contraceptive agents: structure activity relationships in a series of norethisterone and levonorgestrel esters.
    Bialy G; Blye RP; Enever RP; Naqvi RH; Lindberg MC
    Steroids; 1983 Mar; 41(3):419-39. PubMed ID: 6419411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting contraceptive agents: furylalkylcarboxylic acid esters of norethisterone.
    Wan AS; Ngiam TL; Leung SL; Go ML; Kielczewski M; Gawronska K; Gawronski J
    Steroids; 1983 Mar; 41(3):321-6. PubMed ID: 6658879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting contraceptive agents: in vitro hydrolysis of esters of norethisterone and levonorgestrel.
    Naderi S; Fotherby K
    Steroids; 1983 Mar; 41(3):397-417. PubMed ID: 6419410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting contraceptive agents: design of the WHO Chemical Synthesis Programme.
    Crabbé P; Archer S; Benagiano G; Diczfalusy E; Djerassi C; Fried J; Higuchi T
    Steroids; 1983 Mar; 41(3):243-53. PubMed ID: 6658872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting contraceptive agents: bile acid esters of norethisterone.
    Herz JE; Sandoval J
    Steroids; 1983 Mar; 41(3):327-31. PubMed ID: 6658880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting contraceptive agents: norethisterone esters of arylcarboxylic acids.
    Wan AS; Ngiam TL; Leung SL; Go ML; Heng PW; Natarajan PN; Shafiee A; Vossoghi M; Savabi F; Francisco CG
    Steroids; 1983 Mar; 41(3):309-20. PubMed ID: 6658878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting contraceptive agents: norethisterone esters of monoalkenyl and monoalkynyl acids.
    Francisco CG; Freire R; Hernandez R; Salazar JA; Suarez E; García de la Mora GA; Noguez JA; Acosta A; Jimeno O
    Steroids; 1983 Mar; 41(3):267-75. PubMed ID: 6658874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives.
    Johansson ED; Elamsson K; Elmestedt U
    Gynecol Obstet Invest; 1982; 14(2):97-105. PubMed ID: 6811379
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-acting contraceptive agents: testosterone esters of unsaturated acids.
    Francisco CG; Freire R; Gawronski J; Hernández R; Kielczewski M; Salazar JA; Savabi F; Shafiee A; Strekowski L; Suárez E
    Steroids; 1990 Jan; 55(1):36-9. PubMed ID: 2309256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting steroids provide new options.
    Netw Res Triangle Park N C; 1988; 9(3):1-3, 7. PubMed ID: 12315656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S; Elicio N; Cordera R; Gapitanio GL; Montagna G; Croce S; Saturnino M; Balestreri R; De Cecco L
    Acta Obstet Gynecol Scand; 1987; 66(4):327-32. PubMed ID: 2962417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants.
    Croxatto HB; Diaz S; Pavez M; Miranda P; Brandeis A
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):307-11. PubMed ID: 6814139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting contraceptive agents: cyclopropyl and cyclobutyl esters of norethisterone.
    Shafiee A; Vossoghi M; Savabi F; Vlahov R; Tarpanov V; Boshkova-Ljapova M; Milenkov B; Stoilova V; Vlahov J; Snatzke G
    Steroids; 1983 Mar; 41(3):291-307. PubMed ID: 6658877
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.